The Gross Law Firm Reminds Organon & Co. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 – OGN
GlobeNewswire News Room· 2025-07-03 04:02
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Organon & Co. (NYSE: OGN). Shareholders who purchased shares of OGN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/organon-co-loss-submission-form/?id=155074&from=3 CLASS PERIOD: October 31, 2024 to Apri ...
WOOF INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Petco Health and Wellness Company, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
GlobeNewswire News Room· 2025-07-03 04:00
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Petco Health and Wellness Company, Inc. (“Petco” or “the Company”) (NASDAQ: WOOF) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise ...
3D Systems Corporation Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before August 12, 2025 to Discuss Your Rights – DDD
GlobeNewswire News Room· 2025-07-03 04:00
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of 3D Systems Corporation (NYSE: DDD). Shareholders who purchased shares of DDD during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/3d-systems-corporation-loss-submission-form/?id=155073&from=3 CLASS PERIOD: Aug ...
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 21, 2025 in DoubleVerify Holdings, Inc. Lawsuit – DV
GlobeNewswire News Room· 2025-07-03 04:00
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DoubleVerify Holdings, Inc. (NYSE: DV). Shareholders who purchased shares of DV during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/doubleverify-holdings-inc-loss-submission-form-2/?id=155071&from=3 CLASS PER ...
atai Life Sciences price target boosted on robust BPL-003 mid-stage trial results
Proactiveinvestors NA· 2025-07-03 03:59
About this content About Emily Jarvie Emily began her career as a political journalist for Australian Community Media in Hobart, Tasmania. After she relocated to Toronto, Canada, she reported on business, legal, and scientific developments in the emerging psychedelics sector before joining Proactive in 2022. She brings a strong journalism background with her work featured in newspapers, magazines, and digital publications across Australia, Europe, and North America, including The Examiner, The Advocate, ...
Investors who lost money on West Pharmaceutical Services, Inc. (WST) should contact The Gross Law Firm about pending Class Action - WST
GlobeNewswire News Room· 2025-07-03 03:59
NEW YORK, July 02, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of West Pharmaceutical Services, Inc. (NYSE: WST). Shareholders who purchased shares of WST during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/west-pharmaceutical-services-inc-loss-submission-form/?id=155069&fr ...
Shareholders of Sarepta Therapeutics, Inc. Should Contact The Gross Law Firm Before August 25, 2025 to Discuss Your Rights – SRPT
GlobeNewswire News Room· 2025-07-03 03:58
公司诉讼事件 - Sarepta Therapeutics公司面临集体诉讼 指控其在2023年6月22日至2025年6月24日期间发布重大虚假或误导性声明 [3] - 诉讼涉及基因疗法ELEVIDYS的安全性问题 包括未披露患者重大安全风险及试验方案缺陷 [3] - 公司被指隐瞒ELEVIDYS严重不良反应 导致试验招募暂停并引发监管审查风险 [3] 法律程序进展 - 股东参与集体诉讼的截止日期为2025年8月25日 需通过指定链接登记 [4] - 登记股东将获得案件生命周期内的状态更新 无需承担参与成本 [4] - 牵头原告申请截止日期同为2025年8月25日 但非强制参与条件 [1][4] 涉事产品影响 - ELEVIDYS作为治疗杜氏肌营养不良的基因疗法 其现有及扩展批准风险因安全性问题加剧 [3] - 不良反应严重程度直接影响公司临床试验进程 包括暂停给药等操作 [3]
Fortrea Holdings Inc. Sued for Securities Law Violations – Investors Should Contact The Gross Law Firm Before August 1, 2025 to Discuss Your Rights – FTRE
GlobeNewswire News Room· 2025-07-03 03:58
公司诉讼事件 - Fortrea Holdings Inc (NASDAQ: FTRE) 面临集体诉讼 涉及2023年7月3日至2025年2月28日期间购买股票的股东 [3] - 诉讼指控公司在上述期间发布 materially false and/or misleading statements [3] - 公司被指控高估长期项目(Pre-Spin Projects)对2025年收益的贡献 [3] - 公司被指控夸大退出过渡服务协议可能实现的成本节约 [3] - 公司2025年EBITDA目标被指夸大 [3] - 公司分拆后商业模式及业务/财务前景的可行性被指高估 [3] 诉讼时间节点 - 股东需在2025年8月1日前登记参与集体诉讼 [4] - 股东登记后将获得案件进展监控服务 [4] - 申请成为首席原告的截止日期为2025年8月1日 [4] 律师事务所信息 - The Gross Law Firm 负责此集体诉讼案件 [5] - 该律所专注于保护因欺骗、欺诈和非法商业行为受损的投资者权益 [5] - 律所致力于确保企业遵守负责任的商业实践和良好企业公民行为 [5]
Another Reason To Add Rocket Lab: Moving Forward With U.S. Space Defense
Seeking Alpha· 2025-07-03 03:57
公司表现 - Rocket Lab Corporation (NASDAQ: RKLB) 股价自3月中旬以来上涨91% [1] - 2025年火箭发射成功率达到100% [1] 行业背景 - 分析师专注于科技、媒体和电信(TMT)行业 [1] - 分析师拥有20多年市场经验 经历过互联网泡沫、2008年信贷违约和近期AI热潮 [1]
NE10 Bolsters its Leadership Team Appointing Ryder and Young as Sales and Commercial Director's Respectively
GlobeNewswire News Room· 2025-07-03 03:55
公司高管任命 - NE10 Vodka Limited宣布任命两位资深董事Scott Ryder和Simon Young,分别担任全国销售总监和商业总监,以加强公司高管团队[1] - Scott Ryder拥有超过20年饮料行业高管经验,曾在ROKiT drinks、Castle Rock Brewery等公司担任高级管理职位,将负责收入优化、销售策略制定等[2][3] - Simon Young拥有19年行业经验,曾在HB Clark、ROKiT Drinks等公司任职,将负责制定和执行公司商业计划,推动增长[4][5] 高管背景与职责 - Scott Ryder表示对加入NE10感到兴奋,期待与团队合作,为顾客、合作伙伴和股东创造价值[4] - Simon Young对市场动态、产品创新和客户参与有深刻理解,其建立战略合作伙伴关系的能力将加速公司在烈酒市场的增长[5] - 公司董事总经理Paul Carroll表示两位新董事对高端烈酒竞争格局有深刻理解,他们的管理专长将帮助巩固公司在风味伏特加领域的领导地位[6] 公司战略发展 - 此次任命正值公司关键时期,新董事将专注于推动英国和美国等关键市场的增长[6] - 公司致力于保持核心价值的同时实现国内外增长,继续为消费者提供高端风味伏特加饮料[6] - 公司定位为国际领先饮料企业,专注于高端风味伏特加和即饮罐装饮料的生产和分销[1]